Id2	O
deletion	O
attenuates	O
Apc	B-DISEASE
-	I-DISEASE
deficient	I-DISEASE
ileal	I-DISEASE
tumor	E-DISEASE
formation	O
.	O


The	O
expression	O
level	O
of	O
inhibitor	O
of	O
DNA	O
binding	O
2	O
(	O
Id2	O
)	O
is	O
increased	O
in	O
colorectal	B-DISEASE
carcinomas	E-DISEASE
and	O
is	O
positively	O
correlated	O
with	O
poor	O
prognosis	O
.	O


However	O
,	O
the	O
functional	O
significance	O
of	O
Id2	O
in	O
intestinal	O
tumorigenesis	O
has	O
not	O
been	O
fully	O
defined	O
using	O
genetic	O
approaches	O
.	O


Here	O
,	O
we	O
show	O
that	O
Id2	O
promotes	O
ileal	B-DISEASE
tumor	E-DISEASE
initiation	O
in	O
Apc	O
-	O
deficient	O
mice	O
.	O


Expression	O
of	O
Id2	O
was	O
stimulated	O
by	O
Wnt	O
signaling	O
through	O
the	O
enhancer	O
region	O
of	O
the	O
Id2	O
promoter	O
at	O
the	O
early	O
stage	O
of	O
tumorigenesis	O
in	O
Apc	O
(	O
+	O
/	O
Delta716	O
)	O
(	O
Apc	O
(	O
Delta716	O
)	O
)	O
mice	O
.	O


Genetic	O
depletion	O
of	O
Id2	O
in	O
Apc	O
(	O
Delta716	O
)	O
mice	O
caused	O
~	O
80	O
%	O
reduction	O
in	O
the	O
number	O
of	O
ileal	O
polyps	O
,	O
but	O
had	O
little	O
effect	O
on	O
tumor	S-DISEASE
size	O
.	O


Notably	O
,	O
the	O
lack	O
of	O
Id2	O
increased	O
the	O
number	O
of	O
apoptotic	O
cells	O
in	O
the	O
normal	O
crypt	O
epithelium	O
of	O
the	O
mice	O
.	O


Furthermore	O
,	O
DNA	O
microarray	O
analysis	O
revealed	O
that	O
the	O
expression	O
level	O
of	O
Max	O
dimerization	O
protein	O
1	O
(	O
Mxd1	O
)	O
,	O
known	O
as	O
a	O
c	O
-	O
Myc	O
antagonist	O
,	O
was	O
specifically	O
increased	O
by	O
Id2	O
deletion	O
in	O
the	O
ileal	O
intestinal	O
epithelium	O
of	O
Apc	O
(	O
Delta716	O
)	O
mice	O
.	O


In	O
contrast	O
,	O
the	O
protein	O
level	O
of	O
c	O
-	O
Myc	O
,	O
but	O
not	O
the	O
mRNA	O
level	O
,	O
was	O
decreased	O
by	O
loss	O
of	O
Id2	O
in	O
these	O
mice	O
.	O


These	O
results	O
indicate	O
that	O
loss	O
of	O
Id2	O
inhibits	O
tumor	S-DISEASE
initiation	O
by	O
up	O
-	O
regulation	O
of	O
Mxd1	O
and	O
down	O
-	O
regulation	O
of	O
c	O
-	O
Myc	O
in	O
Apc	O
(	O
Delta716	O
)	O
mice	O
.	O
